Declaring an attempt at negotiating a voluntary licence under Canada's Access to Medicines Regime
The pharmaceutical company must complete and submit to the Commissioner of Patents a Solemn or Statutory Declaration Under Paragraph 21.04(3)(c) of the Patent Act. The form sets out the information that must appear in the declaration, including that the company
An attempt to negotiate a voluntary licence is required to comply with Article 31(b) of the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
Report a problem or mistake on this page
- Date modified: